Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 362

1.

Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India.

Sinha S, Ahmad H, Shekhar RC, Kumar N, Dar L, Samantaray JC, Sharma SK, Bhargava A, Pandey RM, Mitsuyasu RL, Fahey JL.

AIDS Res Treat. 2012;2012:905823. doi: 10.1155/2012/905823. Epub 2012 Mar 15.

2.

Clinical Immunology Society: the early years 1984-1989 : I. An introduction.

Fahey JL.

J Clin Immunol. 2011 Aug;31(4):533-6. doi: 10.1007/s10875-011-9544-4. Epub 2011 May 17. No abstract available.

PMID:
21584708
3.

Origin of CD4 T cell levels of 200 cells/μl as the key marker for AIDS diagnosis and therapy: was 186 cells/μl more precise, but less useful?

Fahey JL.

AIDS. 2011 Jan 2;25(1):13-4. doi: 10.1097/QAD.0b013e32833f6029. No abstract available.

PMID:
21119324
4.

Continuing medical education on antiretroviral therapy in HIV/AIDS in India: needs assessment and impact on clinicians and allied health personnel.

Kabra SK, Mukherjee A, Vani SA, Sinha S, Sharma SK, Mitsuyasu R, Fahey JL.

Natl Med J India. 2009 Sep-Oct;22(5):257-60.

PMID:
20334050
5.

HIV knowledge improvement among nurses in India: using a train-the-trainer program.

Nyamathi A, Vatsa M, Khakha DC, McNeese-Smith D, Leake B, Fahey JL.

J Assoc Nurses AIDS Care. 2008 Nov-Dec;19(6):443-9. doi: 10.1016/j.jana.2008.06.001.

6.

Knowledge and Attitudes about HIV/AIDS among Homoeopathic Practitioners and Educators in India.

Nyamathi A, Singh VP, Lowe A, Khurana A, Taneja D, George S, Fahey JL.

Evid Based Complement Alternat Med. 2008 Jun;5(2):221-5. doi: 10.1093/ecam/nem018.

7.

A pilot study on willingness to participate in future preventive HIV vaccine trials.

Suhadev M, Nyamathi AM, Swaminathan S, Venkatesan P, Raja Sakthivel M, Shenbagavalli R, Suresh A, Fahey JL.

Indian J Med Res. 2006 Dec;124(6):631-40.

PMID:
17287550
8.

Perceptions of a community sample about participation in future HIV vaccine trials in south India.

Nyamathi AM, Suhadev M, Swaminathan S, Fahey JL.

AIDS Behav. 2007 Jul;11(4):619-27. Epub 2006 Oct 3.

9.
10.

Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.

Mildvan D, Spritzler J, Grossberg SE, Fahey JL, Johnston DM, Schock BR, Kagan J.

Clin Infect Dis. 2005 Mar 15;40(6):853-8. Epub 2005 Feb 18.

PMID:
15736019
11.

Acute threat to the social self: shame, social self-esteem, and cortisol activity.

Gruenewald TL, Kemeny ME, Aziz N, Fahey JL.

Psychosom Med. 2004 Nov-Dec;66(6):915-24.

PMID:
15564358
12.

Diurnal cortisol rhythm and fatigue in breast cancer survivors.

Bower JE, Ganz PA, Dickerson SS, Petersen L, Aziz N, Fahey JL.

Psychoneuroendocrinology. 2005 Jan;30(1):92-100.

PMID:
15358446
13.

Immunological effects of induced shame and guilt.

Dickerson SS, Kemeny ME, Aziz N, Kim KH, Fahey JL.

Psychosom Med. 2004 Jan-Feb;66(1):124-31.

PMID:
14747646
14.

Psychological risk factors for HIV pathogenesis: mediation by the autonomic nervous system.

Cole SW, Kemeny ME, Fahey JL, Zack JA, Naliboff BD.

Biol Psychiatry. 2003 Dec 15;54(12):1444-56.

PMID:
14675810
15.

T-cell homeostasis in breast cancer survivors with persistent fatigue.

Bower JE, Ganz PA, Aziz N, Fahey JL, Cole SW.

J Natl Cancer Inst. 2003 Aug 6;95(15):1165-8.

PMID:
12902446
16.

Effects of an exercise intervention on immunologic parameters in frail elderly nursing home residents.

Kapasi ZF, Ouslander JG, Schnelle JF, Kutner M, Fahey JL.

J Gerontol A Biol Sci Med Sci. 2003 Jul;58(7):636-43.

PMID:
12865480
18.
19.

Ebola virus: immune mechanisms of protection and vaccine development.

Nyamathi AM, Fahey JL, Sands H, Casillas AM.

Biol Res Nurs. 2003 Apr;4(4):276-81. Review.

PMID:
12698920
20.

Presence and predictors of hepatitis C virus RNA in the semen of homeless men.

Nyamathi A, Robbins WA, Fahey JL, Wiley D, Pekler VA, Longshore D, Robins TA, Singh J, Saab S.

Biol Res Nurs. 2002 Jul;4(1):22-30.

21.

Fatigue and proinflammatory cytokine activity in breast cancer survivors.

Bower JE, Ganz PA, Aziz N, Fahey JL.

Psychosom Med. 2002 Jul-Aug;64(4):604-11.

PMID:
12140350
22.

Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity.

Cole SW, Naliboff BD, Kemeny ME, Griswold MP, Fahey JL, Zack JA.

Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12695-700.

23.

Idiopathic CD4+ T cell lymphocytopenia evolving to monoclonal immunoglobulins and progressive renal damage responsive to IL-2 therapy.

Wilhelm M, Weissinger F, Kunzmann V, Muller JG, Fahey JL.

Clin Immunol. 2001 May;99(2):298-304.

PMID:
11318602
24.

Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.

Jacobson JM, Greenspan JS, Spritzler J, Fox L, Fahey JL, Jackson JB, Chernoff M, Wohl DA, Pulvirenti JJ, Hooton TM, Shikuma C.

J Infect Dis. 2001 Jan 15;183(2):343-346. Epub 2000 Dec 15.

PMID:
11120935
25.
26.

Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation.

Fahey JL, Aziz N, Spritzler J, Plaeger S, Nishanian P, Lathey JL, Seigel J, Landay AL, Kilarui R, Schmitz JL, White C, Wara DW, Akridge R, Cutili J, Douglas SD, Reuben J, Shearer WT, Nokta M, Polland R, Schooley R, Asthana D, Mizrachi Y, Waxdal M.

Clin Diagn Lab Immunol. 2000 Jul;7(4):540-8.

27.

Distinct categories of immunologic changes in frail elderly.

Fahey JL, Schnelle JF, Boscardin J, Thomas JK, Gorre ME, Aziz N, Sadeghi H, Nishanian P.

Mech Ageing Dev. 2000 May 18;115(1-2):1-20.

PMID:
10854626
28.

Increased natural killer-cell mobilization and cytotoxicity during marital conflict.

Dopp JM, Miller GE, Myers HF, Fahey JL.

Brain Behav Immun. 2000 Mar;14(1):10-26.

PMID:
10729214
29.

Phenotypic and functional characteristics of circulating monocytes of elderly persons.

Sadeghi HM, Schnelle JF, Thoma JK, Nishanian P, Fahey JL.

Exp Gerontol. 1999 Dec;34(8):959-70.

PMID:
10673149
30.

Worry affects the immune response to phobic fear.

Segerstrom SC, Glover DA, Craske MG, Fahey JL.

Brain Behav Immun. 1999 Jun;13(2):80-92.

PMID:
10373274
31.

Psychosocial predictors of natural killer cell mobilization during marital conflict.

Miller GE, Dopp JM, Myers HF, Stevens SY, Fahey JL.

Health Psychol. 1999 May;18(3):262-71.

PMID:
10357507
32.

Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.

Jacobson JM, Spritzler J, Fox L, Fahey JL, Jackson JB, Chernoff M, Wohl DA, Wu AW, Hooton TM, Sha BE, Shikuma CM, MacPhail LA, Simpson DM, Trapnell CB, Basgoz N.

J Infect Dis. 1999 Jul;180(1):61-7.

PMID:
10353862
33.

Clinical laboratory immunology: the future.

Fahey JL.

Clin Diagn Lab Immunol. 1999 May;6(3):291-2. No abstract available.

34.

The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes.

Plaeger S, Bass HZ, Nishanian P, Thomas J, Aziz N, Detels R, King J, Cumberland W, Kemeny M, Fahey JL.

Clin Immunol. 1999 Feb;90(2):238-46.

PMID:
10080836
35.

Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection.

Aziz N, Nishanian P, Taylor JM, Mitsuyasu RT, Jacobson JM, Dezube BJ, Lederman MM, Detels R, Fahey JL.

J Infect Dis. 1999 Apr;179(4):843-8.

PMID:
10068579
36.

Cognitive processing, discovery of meaning, CD4 decline, and AIDS-related mortality among bereaved HIV-seropositive men.

Bower JE, Kemeny ME, Taylor SE, Fahey JL.

J Consult Clin Psychol. 1998 Dec;66(6):979-86.

PMID:
9874911
37.

Variables that affect assays for plasma cytokines and soluble activation markers.

Aziz N, Nishanian P, Mitsuyasu R, Detels R, Fahey JL.

Clin Diagn Lab Immunol. 1999 Jan;6(1):89-95.

38.

Relationship of worry to immune sequelae of the Northridge earthquake.

Segerstrom SC, Solomon GF, Kemeny ME, Fahey JL.

J Behav Med. 1998 Oct;21(5):433-50.

PMID:
9836130
39.

Pentoxifylline is not a promising treatment for multiple sclerosis in progression phase.

Myers LW, Ellison GW, Merrill JE, El Hajjar A, St Pierre B, Hijazin M, Leake BD, Bentson JR, Nuwer MR, Tourtellotte WW, Davis P, Granger D, Fahey JL.

Neurology. 1998 Nov;51(5):1483-6.

PMID:
9818891
40.
41.

Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements.

Fahey JL, Taylor JM, Manna B, Nishanian P, Aziz N, Giorgi JV, Detels R.

AIDS. 1998 Sep 10;12(13):1581-90.

PMID:
9764776
42.

Quantification of cytokine mRNA in peripheral blood mononuclear cells using branched DNA (bDNA) technology.

Shen LP, Sheridan P, Cao WW, Dailey PJ, Salazar-Gonzalez JF, Breen EC, Fahey JL, Urdea MS, Kolberg JA.

J Immunol Methods. 1998 Jun 1;215(1-2):123-34.

PMID:
9744754
43.
44.

Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection.

Salazar-Gonzalez JF, Martinez-Maza O, Nishanian P, Aziz N, Shen LP, Grosser S, Taylor J, Detels R, Fahey JL.

J Infect Dis. 1998 Aug;178(2):423-30.

PMID:
9697722
45.
46.

Oral fluids as an alternative to serum for measurement of markers of immune activation.

Nishanian P, Aziz N, Chung J, Detels R, Fahey JL.

Clin Diagn Lab Immunol. 1998 Jul;5(4):507-12.

47.

Optimism is associated with mood, coping, and immune change in response to stress.

Segerstrom SC, Taylor SE, Kemeny ME, Fahey JL.

J Pers Soc Psychol. 1998 Jun;74(6):1646-55.

PMID:
9654763
48.

Accelerated changes (inflection points) in levels of serum immune activation markers and CD4+ and CD8+ T cells prior to AIDS onset.

Nishanian P, Taylor JM, Manna B, Aziz N, Grosser S, Giorgi JV, Detels R, Fahey JL.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jun 1;18(2):162-70.

PMID:
9637581
49.

Cytokine gene expression in normal human lymphocytes in response to stimulation.

Fan J, Nishanian P, Breen EC, McDonald M, Fahey JL.

Clin Diagn Lab Immunol. 1998 May;5(3):335-40.

50.

Relationship of plasma HIV-RNA levels and levels of TNF-alpha and immune activation products in HIV infection.

Salazar-Gonzalez JF, Martinez-Maza O, Aziz N, Kolberg JA, Yeghiazarian T, Shen LP, Fahey JL.

Clin Immunol Immunopathol. 1997 Jul;84(1):36-45.

PMID:
9191882

Supplemental Content

Loading ...
Support Center